Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 12.83
1.66 %
$ 15.3 B
Market Cap
-17.58
P/E
Price Target
Average
3.55%
Revenue Forecast
Estimate
2.40%
EBIT
Estimate
16.18%
Net Income
Estimate
284.68%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Viatris Inc.
Wall Street analysts predict an average 1-year price target for VTRS of $13.3 , with forecasts ranging from a low of $10 to a high of $15 .
VTRS Lowest Price Target
Wall Street Target
10 USD
-22.06%
VTRS Average Price Target
Wall Street Target
13.3 USD
3.55%
VTRS Highest Price Target
Wall Street Target
15 USD
16.91%
REVENUE FORECAST
Revenue Forecast Chart VTRS
EBIT FORECAST
EBIT Forecast Chart VTRS
NET INCOME FORECAST
Net Income Chart VTRS